For example, several studies identified compounds that enhance SMN2 exon 7 splicing to promote the production of a full-length SMN protein [102,168,169], which is promising for therapeutic utility for spinal muscular atrophy. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.